Catalyst Wire Dossier Catalyst Wire Dossier

SILIQ

brodalumab · Bausch Health US LLC
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for SILIQ, covering 2017-02-15 to 2026-02-27. Get the full timeline:

Most recent: FDA Approved: SILIQ — Supplemental Application (Bausch Health US LLC)

See pricing